A single amino-acid change in ERK1/2 makes the enzyme susceptible to PP1 derivatives

Biochemical and Biophysical Research Communications

Volumn 341, Issue 1, 2006, Pages 261-265

  Endo, Shogo ^a   Satoh, Yasushi ^b   Shah, Kavita ^c   Takishima, Kunio ^b  

^a OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

ERK; Mutagenesis; Src inhibitor

Indexed keywords

AMINO ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ENZYME ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PYRAZOLES; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; MAMMALIA;

EID: 30944438639     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.12.179     Document Type: Article

References (16)

1. S.K. Hanks, and T. Hunter The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification FASEB J. 9 1995 576 596
2. A.C. Bishop, J.A. Ubersax, D.T. Petsch, D.P. Matheos, N.S. Gray, J. Blethrow, E. Shimizu, J.Z. Tsien, P.G. Schultz, M.D. Rose, J.L. Wood, D.O. Morgan, and K.M. Shokat A chemical switch for inhibitor-sensitive alleles of any protein kinase Nature 407 2000 395 401
3. A.C. Bishop, C.-Y. Kung, K. Shah, L. Witucki, K.M. Shokat, and Y. Liu Generation of monospecific nanomolar tyrosine kinase inhibitors via a chemical genetic approach J. Am. Chem. Soc. 121 1999 627 631
4. M.M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
5. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
6. K. Shah, and K.M. Shokat A chemical genetic screen for direct v-Src substrates reveals ordered assembly of a retrograde signaling pathways Chem. Biol. 9 2002 35 47
7. K. Shah, Y. Liu, C. Deirmengian, and K.M. Shokat Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates Proc. Natl. Acad. Sci. USA 94 1997 3565 3570
8. Y. Liu, K. Shah, F. Yang, L. Witucki, and K.M. Shokat A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src Bioorg. Med. Chem. 6 1998 1219 1226
9. H. Habelhah, K. Shah, L. Huang, A.L. Burlingame, K.M. Shokat, and Z. Ronai Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue J. Biol. Chem. 276 2001 18090 18095
10. J.D. Sweatt The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory J. Neurochem. 76 2001 1 10
11. J. Pouyssegur, V. Volmat, and P. Lenormand Fidelity and spatio-temporal control in MAP kinase (ERKs) signaling Biochem. Pharmacol. 64 2002 755 763
12. M. Kohno, and J. Pouyssegur Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs Prog. Cell Cycle Res. 5 2003 219 224
13. G. Pages, S. Guerin, D. Grall, F. Bonino, A. Smith, F. Anjuere, P. Auberger, and J. Pouyssegur Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice Science 286 1999 1374 1377
14. C. Mazzucchelli, C. Vantaggiato, A. Ciamei, S. Fasano, P. Pakhotin, W. Krezel, H. Welzl, D.P. Wolfer, G. Pages, O. Valverde, A. Marowsky, A. Porrazzo, P.C. Orban, R. Maldonado, M.U. Ehrengruber, V. Cestari, H.P. Lipp, P.F. Chapman, J. Pouyssegur, and R. Brambilla Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory Neuron 34 2002 807 820
15. F. Bost, M. Aouadi, L. Caron, P. Even, N. Belmonte, M. Prot, C. Dani, P. Hofman, G. Pages, J. Pouyssegur, Y. Le Marchand-Brustel, and B. Binetruy The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis Diabetes 54 2005 402 411
16. D.J. Lips, O.F. Bueno, B.J. Wilkins, N.H. Purcell, R.A. Kaiser, J.N. Lorenz, L. Voisin, M.K. Saba-El-Leil, S. Meloche, J. Pouyssegur, G. Pages, L.J. De Windt, P.A. Doevendans, and J.D. Molkentin MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo Circulation 109 2004 1938 1941